CSE/DOSE (CSE/DOSE)

Canadian Securities Exchange: CSE/DOSE · CAD

CA$0.11

+0.01 (+10.0%)· Recorded snapshot

Market cap	15.2M
Revenue (ttm)	2.6M
Net income (ttm)	-3.2M
EPS (ttm)	-CA$0.02
Shares out	137.8M
Volume	2,000
Beta	-0.85

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6M
Net income (ttm): -3.2M
EPS (ttm): -CA$0.02
Market cap: 15.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/DOSE indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

CAD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-30
Enterprise value	CAD 20.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-05-31
First seen	2026-05-10
Fiscal year end	February
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA75339A1012
Last earnings date	2026-01-29
Last refreshed	2026-10-29
Market cap	CAD 15.2M
Next earnings date	2026-10-30
Price	CAD 0.11
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	cse/DOSE
Website	https://rapid-dose.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-21.47%
EV/FCF	92.89x
EV/Sales	7.6x
FCF / EV yield	1.08%
FCF yield	1.53%
P/FCF ratio	65.4x
P/OCF ratio	65.4x
P/S ratio	5.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-73.59%
EBITDA margin	-70.78%
FCF margin	8.18%
Gross margin	49.83%
Operating margin	-73.59%
Pretax margin	-123.09%
Profit margin	-123.09%
ROA	-33.3%
ROA (5Y)	-91.6%
ROCE	33.87%
SBC / revenue	9.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	6
EPS growth years	1
FCF growth (QoQ)	-92.64%
Gross profit growth	-2.42%
Gross profit growth (Q)	-20.39%
Gross profit growth 3Y	42.55%
Gross profit growth 5Y	-2.09%
Net income growth quarters	6
Net income growth years	1
OCF growth (QoQ)	-92.64%
Revenue growth	4.3%
Revenue growth (Q)	-25.32%
Revenue growth (QoQ)	-11.51%
Revenue growth 3Y	42.11%
Revenue growth 5Y	10.28%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD 0
Depreciation and amortization	CAD 72,357
EBIT	CAD -1.9M
EBITDA	CAD -1.8M
EPS	CAD -0.02
FCF per share	CAD 0.00
Financing cash flow	CAD -268,532
Free cash flow	CAD 210,688
Free cash flow minus SBC	CAD -22,750
Gross profit	CAD 1.3M
Net borrowing	CAD 109,115
Net cash flow	CAD -57,844
Net income	CAD -3.2M
Operating cash flow minus SBC	CAD -22,750
Operating income	CAD -1.9M
Revenue	CAD 2.6M
Stock-based compensation	CAD 233,438

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-24.98
Book value per share	CAD -0.06
Debt / FCF	27.56
Interest coverage	-1.49
Long-term assets	CAD 2.8M
Long-term liabilities	CAD 1.9M
Net cash (debt)	CAD -5.8M
Net cash / market cap	-42.04%
Net debt / FCF	27.49
Piotroski F-Score	2
Property, plant and equipment	CAD 2.7M
Shareholders' equity	CAD -7.5M
Tangible book value	CAD -7.5M
Tangible book value per share	CAD -0.06
Total assets	CAD 3.1M
Total cash	CAD 14,653
Total debt	CAD 5.8M
Total liabilities	CAD 10.7M
WACC	4.83%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.72
Current assets	CAD 324,442
Current liabilities	CAD 8.7M
Current ratio	0.04
Inventory turnover	6.09
Net working capital	CAD -4.5M
Quick ratio	0.02
Working capital	CAD -8.4M
Working capital turnover	-0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.68%
Shareholder yield	-5.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.11
1D price change	10%
1M price change	15.79%
1M total return	15.79%
1W price change	22.22%
1W total return	22.22%
1Y price change	-31.25%
1Y return CAGR	-31.27%
1Y total return	-31.25%
20-day SMA	CAD 0.10
200-day SMA	CAD 0.12
3M price change	15.79%
3M total return	15.79%
3Y price change	-51.11%
3Y return CAGR	-21.22%
3Y total return	-51.11%
50-day SMA	CAD 0.10
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.19
52-week high date	2025-11-21
52-week low	CAD 0.08
52-week low date	2026-10-20
5Y price change	-82.26%
5Y return CAGR	-29.24%
5Y total return	-82.26%
6M price change	15.79%
6M total return	15.79%
All-time high	CAD 1.33
All-time high date	2019-01-04
All-time low	CAD 0.07
All-time low date	2022-08-25
Average true range (ATR)	CAD 0.01
Average volume	31.3K
Beta (1Y)	1.49
Beta (2Y)	0.56
Beta (5Y)	-0.85
Change from 52-week high	-42.11%
Change from 52-week low	37.5%
Change from all-time high	-91.73%
Change from all-time low	57.14%
Change from open	0%
Day's gap	10%
Dollar volume	CAD 220
High price	CAD 0.11
Low price	CAD 0.11
Monthly RSI	41.68
Open price	CAD 0.11
Previous close	CAD 0.10
Price vs 150-day SMA	2.71%
Price vs 20-day SMA	9.78%
Price vs 200-day SMA	-6.3%
Price vs 50-day SMA	6.18%
Relative volume	0.06
RSI	54.69
Sharpe ratio	0.13
Sharpe ratio (3Y)	0.72
Sharpe ratio (5Y)	0.52
Sortino ratio	0.24
Sortino ratio (3Y)	1.2
Sortino ratio (5Y)	0.88
Volume	2K
Weekly RSI	49.3
YTD price change	-15.38%
YTD total return	-15.38%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117M
Shares change (QoQ)	-0.32%
Shares change (YoY)	5.68%
Shares held by insiders	15.06%
Shares outstanding	137.8M

Deeper analysis on CSE/DOSE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/DOSE report

Is a complete CSE/DOSE research report available?

No complete published report is available for cse/DOSE (CSE/DOSE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/DOSE (CSE/DOSE)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/DOSE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/DOSE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/DOSE

Frequently asked questions